Sulfamethoxazole and Trimethoprim Tablets, USP | Sulfamethoxazole and Trimethoprim
| Weight |
Dose–every 12 hours |
|
| lb |
kg |
Tablets |
| 22 44 66 88 |
10 20 30 40 |
– 1 1½ 2 or 1 DS tablet |
| Creatinine Clearance (mL/min) |
Recommended Dosage Regimen |
| Above 30 15–30 Below 15 |
Usual standard regimen ½ the usual regimen Use not recommended |
For the lower limit dose (75 mg/kg sulfamethoxazole and 15 mg/kg trimethoprim per 24 hours) administer 75% of the dose in the above table.
| Weight |
Dose–every 6 hours |
|
| lb |
kg |
Tablets |
| 18 35 53 70 88 106 141 176 |
8 16 24 32 40 48 64 80 |
– 1 1½ 2 or 1 DS tablet 2½ 3 or 1½ DS tablets 4 or 2 DS tablets 5 or 2½ DS tablets |
| Body Surface Area |
Dose–every 12 hours |
| (m2) |
Tablets |
| 0.26 0.53 1.06 |
– ½ 1 |
| Bottles of 30 |
NDC 54868-4711-0 |
| Bottles of 10 |
NDC 54868-0021-6 |
| Bottles of 14 |
NDC 54868-0021-2 |
| Bottles of 15 |
NDC 54868-0021-5 |
| Bottles of 20 |
NDC 54868-0021-1 |
| Bottles of 30 |
NDC 54868-0021-7 |
| Bottles of 60 |
NDC 54868-0021-4 |
| Bottles of 100 |
NDC 54868-0021-0 |
| Bottles of 120 |
NDC 54868-0021-3 |
Relabeling and Repackaging by: Physicians Total Care, Inc.Tulsa, OK 74146
Manufacturer
Physicians Total Care, Inc.
Active Ingredients
Source
- U.S. National Library of Medicine
- DailyMed
- Last Updated: 4 May 2013
Drugs and Medications
Sulfamethoxazole and trimethoprim [Teva Parenteral Medicines, Inc]
Sulfamethoxazole and Trimethoprim Injection, USP
Sulfamethoxazole and trimethoprim [Aurobindo Pharma Limited]
Sulfamethoxazole and Trimethoprim Oral Suspension, USP
Sulfamethoxazole and trimethoprim [Aurobindo Pharma Limited]
Sulfamethoxazole and Trimethoprim Tablets, USP
SULFAMETHOXAZOLE AND TRIMETHOPRIM ORAL SUSPENSION USP FORM NO. 1284/1285 Rev. 3/06 VC2785
Septra [Monarch Pharmaceuticals, Inc.]
SEPTRA Tablets SEPTRA DS (Double Strength) Tablets (trimethoprim and sulfamethoxazole)
Clinical Trials
The primary objective of the study is to evaluate the effectiveness of l-leucovorin in preventing toxicity from high dose trimethoprim / sulfamethoxazole (TMP / SMX) used as a therapy for...
To evaluate the effectiveness of two oral treatments for mild to moderate Pneumocystis carinii pneumonia (PCP): dapsone/trimethoprim or clindamycin/primaquine as compared to a standard tr...
To compare the safety and effectiveness of an investigational drug therapy (trimetrexate plus leucovorin calcium) with that of conventional therapy (sulfamethoxazole-trimethoprim) in the t...
Trimethoprim-Sulfamethoxazole or Doxycycline for Skin and Soft Tissue Infections
Background: In many communities, skin and soft tissue infections (SSTI) with MRSA have become more prevalent than infections with β-lactam susceptible bacteria. This has necessitated alt...
To compare the safety and efficacy of two dosage regimens (daily and thrice-weekly) of sulfamethoxazole/trimethoprim (SMX/TMP; TMS) in the prevention of Pneumocystis carinii pneumonia (PCP...
PubMed Articles
Edwardsiella tarda, a catalase-positive bacillus widely distributed throughout nature, is generally susceptible to trimethoprim/sulfamethoxazole. We describe osteomyelitis due to trimethoprim/sulfamet...
BACKGROUND. Although the use of antibiotics in the treatment of acute exacerbation of chronic obstructive pulmonary disease (COPD) is largely accepted, controversy remains regarding whether the choice...
Failure and relapse after treatment with trimethoprim/sulfamethoxazole in classic Whipple's disease.
Objectives Classic Whipple's disease is a chronic disease caused by Tropheryma whipplei. A recent study reported that intravenous treatment with ceftriaxone or meropenem followed by a 1 year treatment...
Considerations when prescribing trimethoprim-sulfamethoxazole.
Escherichia coli was the most commonly isolated pathogen in the Canadian Ward Surveillance Study 2007-2009 (3789 isolates). Susceptibility to cefazolin (34.1%), trimethoprim-sulfamethoxazole (73.8%),...
